The Diagnostic Center for Disease has announced the grand opening of its world headquarters in Sarasota, FL is scheduled for December 2006. The center offers advanced detection imaging technology and interpretation for prostate disease while featuring a 3.0 Tesla Signa HD-X Magnetic Resonance Imaging Spectroscopy (MRIS) scanner from GE Healthcare. The signature "Prostascan" image technology will provide a unique biochemical "finger print" of cancerous tissue (when present) as it evaluates the by- products of metabolism at the prostate cellular level.
"In effect, with my clinical experience, this scan will help us decode the disease, enabling better decisions and better treatment outcomes," states Dr. Ronald Wheeler, urologist and medical director for The Diagnostic Center for Disease.


Additional Content

News | Radiology Imaging

Nov. 2, 2026 — Neurophet and RapidAI have partnered to integrate Neurophet’s advanced neurodegenerative brain imaging ...

Time November 04, 2026
arrow
News | Radiology Imaging

Oct. 19, 2026 — Paradromics Inc. has announced a collaboration with Siemens Healthineers to develop an advanced ...

Time October 26, 2026
arrow
News | FDA

Oct.7, 2026 – MRI2CT Inc. has received FDA 510(k) clearance for NextMR, its AI powered imaging platform, for generating ...

Time October 07, 2026
arrow
News | Information Technology

October 6, 2026 – Clearsense has introduced a cloud-based medical image archive designed to reduce the cost of ...

Time October 07, 2026
arrow
News | PET-MRI

Sept. 29, 2026 —Yale New Haven Hospital has installed a state-of-the-art positron emission tomography/magnetic resonance ...

Time October 05, 2026
arrow
Subscribe Now